FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:141 January 14, 1993 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

To the Editor: The editorial by Cheson (Aug. 6 issue)¹ mentions the bcl-2 oncogene in follicular B-cell non-Hodgkin's lymphoma. The chromosomal location of this oncogene is incorrectly identified. This oncogene was cloned at the site of the t(14;18) (q32;q21) breakpoint² rather than at the t(11;14) translocation. The bcl-1 oncogene has been characterized at the t(11;14) (q13;q32) breakpoint³.

The product of the fusion of the PML gene to the retinoic acid receptor-alpha gene that results from the t(15;17) translocation is similar to the product of the fusion of bcr and abl, in that perturbation of both genes may contribute to . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.